The metastasis-promoting roles of tumor-associated immune cells
- PMID: 23515621
- PMCID: PMC3697909
- DOI: 10.1007/s00109-013-1021-5
The metastasis-promoting roles of tumor-associated immune cells
Abstract
Tumor metastasis is driven not only by the accumulation of intrinsic alterations in malignant cells, but also by the interactions of cancer cells with various stromal cell components of the tumor microenvironment. In particular, inflammation and infiltration of the tumor tissue by host immune cells, such as tumor-associated macrophages, myeloid-derived suppressor cells, and regulatory T cells, have been shown to support tumor growth in addition to invasion and metastasis. Each step of tumor development, from initiation through metastatic spread, is promoted by communication between tumor and immune cells via the secretion of cytokines, growth factors, and proteases that remodel the tumor microenvironment. Invasion and metastasis require neovascularization, breakdown of the basement membrane, and remodeling of the extracellular matrix for tumor cell invasion and extravasation into the blood and lymphatic vessels. The subsequent dissemination of tumor cells to distant organ sites necessitates a treacherous journey through the vasculature, which is fostered by close association with platelets and macrophages. Additionally, the establishment of the pre-metastatic niche and specific metastasis organ tropism is fostered by neutrophils and bone marrow-derived hematopoietic immune progenitor cells and other inflammatory cytokines derived from tumor and immune cells, which alter the local environment of the tissue to promote adhesion of circulating tumor cells. This review focuses on the interactions between tumor cells and immune cells recruited to the tumor microenvironment and examines the factors allowing these cells to promote each stage of metastasis.
Conflict of interest statement
The authors declare that they have no conflict of interests.
Figures
Similar articles
-
Myeloid regulatory cells in tumor spreading and metastasis.Immunobiology. 2015 Feb;220(2):236-42. doi: 10.1016/j.imbio.2014.07.017. Epub 2014 Jul 23. Immunobiology. 2015. PMID: 25178934 Review.
-
The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.Front Immunol. 2020 Dec 22;11:598532. doi: 10.3389/fimmu.2020.598532. eCollection 2020. Front Immunol. 2020. PMID: 33414786 Free PMC article. Review.
-
[Role of the stroma in the initiation and progression of tumors].Orv Hetil. 2015 Nov 8;156(45):1816-23. doi: 10.1556/650.2015.30294. Orv Hetil. 2015. PMID: 26522855 Review. Hungarian.
-
Neutrophils: important contributors to tumor progression and metastasis.Cancer Metastasis Rev. 2015 Dec;34(4):735-51. doi: 10.1007/s10555-015-9594-9. Cancer Metastasis Rev. 2015. PMID: 26361774 Review.
-
Myeloid Cells in Metastasis.Cold Spring Harb Perspect Med. 2020 May 1;10(5):a038026. doi: 10.1101/cshperspect.a038026. Cold Spring Harb Perspect Med. 2020. PMID: 31548218 Free PMC article. Review.
Cited by
-
Antagonizing Integrin β3 Increases Immunosuppression in Cancer.Cancer Res. 2016 Jun 15;76(12):3484-95. doi: 10.1158/0008-5472.CAN-15-2663. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216180 Free PMC article.
-
Metastatic niche functions and therapeutic opportunities.Nat Cell Biol. 2018 Aug;20(8):868-877. doi: 10.1038/s41556-018-0145-9. Epub 2018 Jul 26. Nat Cell Biol. 2018. PMID: 30050120 Review.
-
Effects of tumor metabolic microenvironment on regulatory T cells.Mol Cancer. 2018 Nov 26;17(1):168. doi: 10.1186/s12943-018-0913-y. Mol Cancer. 2018. PMID: 30477520 Free PMC article. Review.
-
Reactive oxygen species: a volatile driver of field cancerization and metastasis.Mol Cancer. 2019 Mar 30;18(1):65. doi: 10.1186/s12943-019-0961-y. Mol Cancer. 2019. PMID: 30927919 Free PMC article. Review.
-
Targeting tumor-stromal interactions in bone metastasis.Pharmacol Ther. 2014 Feb;141(2):222-33. doi: 10.1016/j.pharmthera.2013.10.006. Epub 2013 Oct 15. Pharmacol Ther. 2014. PMID: 24140083 Free PMC article. Review.
References
-
- Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. Journal of cellular physiology. 2003;195:346–355. - PubMed
-
- Bui JD, Schreiber RD. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Current opinion in immunology. 2007;19:203–208. - PubMed
-
- de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nature reviews Cancer. 2006;6:24–37. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources